- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 20 x SO4: SULFATE ION(Non-functional Binders)
- 8 x MG: MAGNESIUM ION(Non-covalent)
MG.6: 3 residues within 4Å:- Chain A: D.52, D.54, D.351
6 PLIP interactions:3 interactions with chain A, 3 Ligand-Water interactions- Metal complexes: A:D.52, A:D.54, A:D.351, H2O.1, H2O.2, H2O.3
MG.7: 2 residues within 4Å:- Chain A: R.446
- Chain C: K.344
No protein-ligand interaction detected (PLIP)MG.17: 3 residues within 4Å:- Chain B: D.52, D.54, D.351
6 PLIP interactions:3 interactions with chain B, 3 Ligand-Water interactions- Metal complexes: B:D.52, B:D.54, B:D.351, H2O.10, H2O.11, H2O.12
MG.18: 2 residues within 4Å:- Chain B: R.446
- Chain D: K.344
No protein-ligand interaction detected (PLIP)MG.28: 3 residues within 4Å:- Chain C: D.52, D.54, D.351
6 PLIP interactions:3 interactions with chain C, 3 Ligand-Water interactions- Metal complexes: C:D.52, C:D.54, C:D.351, H2O.19, H2O.20, H2O.20
MG.29: 2 residues within 4Å:- Chain A: K.344
- Chain C: R.446
No protein-ligand interaction detected (PLIP)MG.39: 3 residues within 4Å:- Chain D: D.52, D.54, D.351
6 PLIP interactions:3 interactions with chain D, 3 Ligand-Water interactions- Metal complexes: D:D.52, D:D.54, D:D.351, H2O.27, H2O.28, H2O.29
MG.40: 2 residues within 4Å:- Chain B: K.344
- Chain D: R.446
No protein-ligand interaction detected (PLIP)- 16 x GOL: GLYCEROL(Non-functional Binders)
GOL.8: 9 residues within 4Å:- Chain A: Q.280, S.281, F.283, D.284, I.286, Q.322, H.323, G.324, I.325
Ligand excluded by PLIPGOL.9: 8 residues within 4Å:- Chain A: S.93, P.96, T.97, E.374, E.378, Y.434, G.438, L.440
Ligand excluded by PLIPGOL.10: 3 residues within 4Å:- Chain A: D.7, P.63, E.64
Ligand excluded by PLIPGOL.11: 8 residues within 4Å:- Chain A: D.252, Y.253, V.288, D.289, V.305, G.310, K.311, L.312
Ligand excluded by PLIPGOL.19: 9 residues within 4Å:- Chain B: Q.280, S.281, F.283, D.284, I.286, Q.322, H.323, G.324, I.325
Ligand excluded by PLIPGOL.20: 8 residues within 4Å:- Chain B: S.93, P.96, T.97, E.374, E.378, Y.434, G.438, L.440
Ligand excluded by PLIPGOL.21: 3 residues within 4Å:- Chain B: D.7, P.63, E.64
Ligand excluded by PLIPGOL.22: 8 residues within 4Å:- Chain B: D.252, Y.253, V.288, D.289, V.305, G.310, K.311, L.312
Ligand excluded by PLIPGOL.30: 9 residues within 4Å:- Chain C: Q.280, S.281, F.283, D.284, I.286, Q.322, H.323, G.324, I.325
Ligand excluded by PLIPGOL.31: 8 residues within 4Å:- Chain C: S.93, P.96, T.97, E.374, E.378, Y.434, G.438, L.440
Ligand excluded by PLIPGOL.32: 3 residues within 4Å:- Chain C: D.7, P.63, E.64
Ligand excluded by PLIPGOL.33: 8 residues within 4Å:- Chain C: D.252, Y.253, V.288, D.289, V.305, G.310, K.311, L.312
Ligand excluded by PLIPGOL.41: 9 residues within 4Å:- Chain D: Q.280, S.281, F.283, D.284, I.286, Q.322, H.323, G.324, I.325
Ligand excluded by PLIPGOL.42: 8 residues within 4Å:- Chain D: S.93, P.96, T.97, E.374, E.378, Y.434, G.438, L.440
Ligand excluded by PLIPGOL.43: 3 residues within 4Å:- Chain D: D.7, P.63, E.64
Ligand excluded by PLIPGOL.44: 8 residues within 4Å:- Chain D: D.252, Y.253, V.288, D.289, V.305, G.310, K.311, L.312
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Guillon, R. et al., Lead optimization and biological evaluation of fragment-based cN-II inhibitors. Eur J Med Chem (2019)
- Release Date
- 2019-03-06
- Peptides
- Cytosolic purine 5'-nucleotidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 20 x SO4: SULFATE ION(Non-functional Binders)
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 16 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Guillon, R. et al., Lead optimization and biological evaluation of fragment-based cN-II inhibitors. Eur J Med Chem (2019)
- Release Date
- 2019-03-06
- Peptides
- Cytosolic purine 5'-nucleotidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A